Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > Rutala's State of Science of Reprocessing Endoscopes: AJIC
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(15)
•••
Comment by Dr.Cashon Jun 05, 2019 6:48pm
135 Views
Post# 29801200

RE:Rutala's State of Science of Reprocessing Endoscopes: AJIC

RE:Rutala's State of Science of Reprocessing Endoscopes: AJICHere is another worth while read: • Endoscope manufacturers must make their endoscopes compatible with LTST (eg, adhesives and lubricants [such as molybdenum disulfide]). The FDA must ensure endoscope manufacturers facilitate compatibility with LTST.
Read more at https://stockhouse.com/companies/bullboard?symbol=t.tos&postid=29798457#qD4zLB9qv4XH3Sgi.99
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities